Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer

Overview of attention for article published in Journal of Translational Medicine, August 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,395 followers.

MET activation predicts poor outcome to cetuximab in patients with recurrent/metastatic head and neck cancer #hncsm http://t.co/ehCMxXnQcc

An article I edited (Madoz-Gúrpide et al., 2015) has been published in the Journal of Translational Medicine http://t.co/dC89edEc04

#Translational #Medicine Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent o… http://t.co/xx5XdrajjH

Activation of MET pathway predicts poor outcome to cetuximab in patients with… http://t.co/sMzos1WFWt #JTransMed

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.